Home/Hedge Fund Intelligence/BridgeBio Pharma, Inc.
Nasdaq: BBIOStockForm 13F30 Jun 2026

Hedge funds that hold BridgeBio Pharma, Inc. Nasdaq: BBIO

CUSIP 10806X102 · who reports it, how much, and how much it matters to them

46 of the 720 hedge fund managers we track reported shares of BridgeBio Pharma, Inc. (Nasdaq: BBIO) on Form 13F for 30 June 2026. Between them they reported USD 4.5bn. The largest position belongs to Kohlberg Kravis Roberts & Co., at USD 988m.

Managers reporting it46of 720 we track
Value they reportUSD 4.5bnshares only, 30 Jun 2026
Funds they run797with a file on PPLI.com
Largest positionUSD 988mKohlberg Kravis Roberts & Co.
Typical weight0.1%median share of a manager's book
Heaviest weight17.3%Kohlberg Kravis Roberts & Co.

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

46 managers, USD 4.5bn between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports BridgeBio Pharma, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Kohlberg Kravis Roberts & Co.34 funds on PPLI.comUSD 988m17.3%
2Farallon Capital Management56 funds on PPLI.comUSD 800m3.7%
3Viking Global Investors4 funds on PPLI.comUSD 741m2.1%
4Two Sigma Investments35 funds on PPLI.comUSD 352m0.3%
5Citadel Advisors32 funds on PPLI.comUSD 280m0.0%
6D. E. Shaw & Co.15 funds on PPLI.comUSD 271m0.1%
7Adage Capital Management1 fund on PPLI.comUSD 168m0.2%
8Polar Capital LLP26 funds on PPLI.comUSD 154m0.4%
9POINT72 Asset Management17 funds on PPLI.comUSD 114m0.1%
10Balyasny Asset Management25 funds on PPLI.comUSD 92m0.1%
11Squarepoint Ops7 funds on PPLI.comUSD 89m0.1%
12Renaissance Technologies13 funds on PPLI.comUSD 64m0.1%
13Summit Partners Public Asset Management14 funds on PPLI.comUSD 46m0.8%
14Cormorant Asset Management1 fund on PPLI.comUSD 41m2.1%
15Millennium Management6 funds on PPLI.comUSD 36m0.0%
16Bridgewater Associates45 funds on PPLI.comUSD 33m0.1%
17Boone Capital Management1 fund on PPLI.comUSD 25m5.9%
18Weiss Asset Management5 funds on PPLI.comUSD 24m0.2%
19Marshall Wace LLP84 funds on PPLI.comUSD 21m0.0%
20PFM Health Sciences3 funds on PPLI.comUSD 19m1.6%
21Sphera Funds Management1 fund on PPLI.comUSD 18m2.4%
22Exoduspoint Capital Management7 funds on PPLI.comUSD 17m0.1%
23Brevan Howard Capital Management39 funds on PPLI.comUSD 12m0.1%
24Rock Springs Capital Management2 funds on PPLI.comUSD 11m0.5%
25Voleon Capital Management13 funds on PPLI.comUSD 10m0.2%
26Tudor Investment Corporation10 funds on PPLI.comUSD 5.7m0.0%
27LMR Partners2 funds on PPLI.comUSD 4m0.0%
28Platinum Investment Management11 funds on PPLI.comUSD 3m0.7%
29Engineers Gate Manager1 fund on PPLI.comUSD 2.8m0.0%
30Campbell & Company Investment Adviser8 funds on PPLI.comUSD 2.6m0.1%
31Hudson Bay Capital Management8 funds on PPLI.comUSD 1.9m0.0%
32Exome Asset Management2 funds on PPLI.comUSD 1.4m0.8%
33Boothbay Fund Management2 funds on PPLI.comUSD 1.2m0.0%
34Schonfeld Strategic Advisors30 funds on PPLI.comUSD 995,0000.0%
35HighVista Strategies27 funds on PPLI.comUSD 980,0000.2%
36Diametric Capital2 funds on PPLI.comUSD 692,0000.1%
37The Quarry1 fund on PPLI.comUSD 521,0000.0%
38CIBC Asset Management69 funds on PPLI.comUSD 447,0000.0%
39Lion Point Capital1 fund on PPLI.comUSD 372,0001.8%
40Gabelli & Company Investment Advisers17 funds on PPLI.comUSD 335,0000.0%
41Fulcrum Asset Management LLP7 funds on PPLI.comUSD 321,0000.0%
42Magnetar Financial93 funds on PPLI.comUSD 279,0000.0%
43Bayforest Capital1 fund on PPLI.comUSD 200,0000.2%
44Freestone Grove Partners1 fund on PPLI.comUSD 188,0000.0%
45Walleye Capital8 funds on PPLI.comUSD 114,0000.0%
46Persistent Asset Partners10 funds on PPLI.comUSD 39,1760.0%
Next: where it matters most
Where it matters most

For Kohlberg Kravis Roberts & Co. it is 17.3% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Kohlberg Kravis Roberts & Co.USD 988m17.3%
2Boone Capital ManagementUSD 25m5.9%
3Farallon Capital ManagementUSD 800m3.7%
4Sphera Funds ManagementUSD 18m2.4%
5Viking Global InvestorsUSD 741m2.1%
6Cormorant Asset ManagementUSD 41m2.1%
7Lion Point CapitalUSD 372,0001.8%
8PFM Health SciencesUSD 19m1.6%
9Exome Asset ManagementUSD 1.4m0.8%
10Summit Partners Public Asset ManagementUSD 46m0.8%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds BridgeBio Pharma, Inc.

What is the ticker symbol of BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. trades under the symbol BBIO on the Nasdaq. Its CUSIP, the code used on Form 13F, is 10806X102.

Which hedge funds own BridgeBio Pharma, Inc. (Nasdaq: BBIO)?

46 of the 720 hedge fund managers PPLI.com tracks reported BridgeBio Pharma, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Kohlberg Kravis Roberts & Co. (USD 988m), Farallon Capital Management (USD 800m), Viking Global Investors (USD 741m), Two Sigma Investments (USD 352m) and Citadel Advisors (USD 280m).

How many hedge funds hold BridgeBio Pharma, Inc.?

46 managers in our coverage reported it, and between them they run 797 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on BridgeBio Pharma, Inc.?

Kohlberg Kravis Roberts & Co., where the position was 17.3% of the reported 13F book at 30 June 2026.

Does this show who is short BridgeBio Pharma, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with BridgeBio Pharma, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.